Research: Evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and the Life Sciences Innovative Manufacturing Fund

Office for Artificial Intelligence UK Published: 2026-04-13 23:01:02

Findings from the early‑stage evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund and its successor, the Life Sciences Innovative Manufacturing Fund.

No full content stored. Use “Open Source” to read the original.

Open Source → View topic (Trending) →

Recommended reads

Policy paper: Telecoms Modernisation: Critical National Infrastructure Charter From UK

This document sets out telecoms companies’ approach to protect CNI during telecoms modernisations.

Office for Artificial Intelligence · UK 2026-10-13

Policy paper: Fixed Telecoms Modernisation Charter From UK

This document sets out the steps that telecoms providers should follow when carrying out any current and future fixed telecoms modernisations.

Office for Artificial Intelligence · UK 2026-10-13

Data Use and Access Act 2025: plans for commencement From UK

A summary of the government’s plans for bringing into force provisions in the Data (Use and Access) Act 2025.

Office for Artificial Intelligence · UK 2026-10-12